2026 NPPES data Hematology & Oncology Physician NPI 1972786895 M.D.
Verify on CMS →

Reza Mostofi, M.D.

Hematology & Oncology Physician in Torrance, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.

Federal data — no proprietary rating. We show these CMS records as-is — no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
803
Medicare Part D claims · 149 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
99.1/100
▲ 16 pts above national avg 83.1 · Exceptional
Industry payments
$1.6K
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Reza Mostofi, M.D. reported a CMS MIPS final score of 99.1/100 — above the 83.1 national average — and filed 803 Medicare Part D claims in 2023.

99.1/100
MIPS score · +16 vs avg
803
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Reza Mostofi, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Reza Mostofi, M.D. sits

This provider among hematology & oncology physician peers

Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Reza Mostofi, M.D. writes more Part D claims than 53% of them and scores higher on MIPS quality than 88% — placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume — percentile in specialtyMIPS quality — percentilePart D claim volume — percentile in specialty: 72 · MIPS quality — percentile: 8Part D claim volume — percentile in specialty: 98 · MIPS quality — percentile: 63Part D claim volume — percentile in specialty: 48 · MIPS quality — percentile: 40Part D claim volume — percentile in specialty: 38 · MIPS quality — percentile: 77Part D claim volume — percentile in specialty: 22 · MIPS quality — percentile: 23Part D claim volume — percentile in specialty: 93 · MIPS quality — percentile: 92Part D claim volume — percentile in specialty: 17 · MIPS quality — percentile: 60Part D claim volume — percentile in specialty: 58 · MIPS quality — percentile: 78Part D claim volume — percentile in specialty: 25 · MIPS quality — percentile: 92Part D claim volume — percentile in specialty: 83 · MIPS quality — percentile: 72Part D claim volume — percentile in specialty: 5 · MIPS quality — percentile: 25Part D claim volume — percentile in specialty: 88 · MIPS quality — percentile: 35Part D claim volume — percentile in specialty: 7 · MIPS quality — percentile: 57Part D claim volume — percentile in specialty: 18 · MIPS quality — percentile: 47Part D claim volume — percentile in specialty: 20 · MIPS quality — percentile: 30Part D claim volume — percentile in specialty: 40 · MIPS quality — percentile: 10Part D claim volume — percentile in specialty: 3 · MIPS quality — percentile: 73Part D claim volume — percentile in specialty: 67 · MIPS quality — percentile: 2Part D claim volume — percentile in specialty: 77 · MIPS quality — percentile: 33Part D claim volume — percentile in specialty: 65 · MIPS quality — percentile: 92Part D claim volume — percentile in specialty: 50 · MIPS quality — percentile: 47Part D claim volume — percentile in specialty: 33 · MIPS quality — percentile: 90Part D claim volume — percentile in specialty: 43 · MIPS quality — percentile: 40Part D claim volume — percentile in specialty: 85 · MIPS quality — percentile: 0Part D claim volume — percentile in specialty: 55 · MIPS quality — percentile: 82Part D claim volume — percentile in specialty: 87 · MIPS quality — percentile: 37Part D claim volume — percentile in specialty: 60 · MIPS quality — percentile: 92Part D claim volume — percentile in specialty: 23 · MIPS quality — percentile: 38Part D claim volume — percentile in specialty: 80 · MIPS quality — percentile: 47Part D claim volume — percentile in specialty: 92 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 15 · MIPS quality — percentile: 70Part D claim volume — percentile in specialty: 30 · MIPS quality — percentile: 80Part D claim volume — percentile in specialty: 27 · MIPS quality — percentile: 85Part D claim volume — percentile in specialty: 0 · MIPS quality — percentile: 67Part D claim volume — percentile in specialty: 82 · MIPS quality — percentile: 15Part D claim volume — percentile in specialty: 28 · MIPS quality — percentile: 3Part D claim volume — percentile in specialty: 70 · MIPS quality — percentile: 75Part D claim volume — percentile in specialty: 75 · MIPS quality — percentile: 53Part D claim volume — percentile in specialty: 57 · MIPS quality — percentile: 17Part D claim volume — percentile in specialty: 90 · MIPS quality — percentile: 92Part D claim volume — percentile in specialty: 78 · MIPS quality — percentile: 45Part D claim volume — percentile in specialty: 13 · MIPS quality — percentile: 28Part D claim volume — percentile in specialty: 47 · MIPS quality — percentile: 7Part D claim volume — percentile in specialty: 33 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 42 · MIPS quality — percentile: 52Part D claim volume — percentile in specialty: 95 · MIPS quality — percentile: 68Part D claim volume — percentile in specialty: 10 · MIPS quality — percentile: 53Part D claim volume — percentile in specialty: 2 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 37 · MIPS quality — percentile: 58Part D claim volume — percentile in specialty: 32 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 73 · MIPS quality — percentile: 5Part D claim volume — percentile in specialty: 8 · MIPS quality — percentile: 43Part D claim volume — percentile in specialty: 100 · MIPS quality — percentile: 83Part D claim volume — percentile in specialty: 68 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 97 · MIPS quality — percentile: 18Part D claim volume — percentile in specialty: 45 · MIPS quality — percentile: 32Part D claim volume — percentile in specialty: 63 · MIPS quality — percentile: 65Part D claim volume — percentile in specialty: 53 · MIPS quality — percentile: 62Part D claim volume — percentile in specialty: 12 · MIPS quality — percentile: 27Part D claim volume — percentile in specialty: 62 · MIPS quality — percentile: 92Reza Mostofi, M.D. — Part D claim volume — percentile in specialty: 53 · MIPS quality — percentile: 88
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Reza Mostofi, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic — not verified)

Reza Mostofi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Reza Mostofi, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 12/13/2007

NPI 1972786895

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

803 5% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

99.1/100 16 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Hematology & Oncology Physician compares to other specialties among California providers

California providers

Largest specialties in California (% of in-state providers)

Behavior Technician — 17.3%Behavior Technician17.3%Marriage & Family Therapist — 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program — 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor — 3.9%Mental Health Counselor3.9%Pharmacist — 3.5%Pharmacist3.5%Clinical Social Worker — 3.1%Clinical Social Worker3.1%Hematology & Oncology Physician — 0.1%Hematology & Oncology Physician0.1%
Largest specialties in California (% of in-state providers)

Medicare quality performance — MIPS

Reza Mostofi, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
99.1/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 99.1/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Hematology & Oncology Physician) — 99.1/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Reza Mostofi, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 5215 TORRANCE BLVD, Torrance, CA, 90503, with a listed phone of (310) 750-1715. NPI 1972786895 was issued on 12/13/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Mostofi most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 803 prescription claims written by this provider, covering 149 Medicare beneficiaries and totaling roughly $3.0 million in drug spend, with an opioid prescribing rate of 3.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.1/100 for the 2023 performance year (Quality 85.2), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5215 TORRANCE BLVD
Torrance, CA 90503

Provider Details

NPI 1972786895
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 12/13/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.1275
Final Score
Avg: 83.1
85.2396
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Reza Mostofi, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

City OF Hope Medical Foundation
South Pasadena, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Reza Mostofi, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.6K

Largest payer

Janssen Biotech, Inc.

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Reza Mostofi, M.D.. To verify Reza Mostofi, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

803
Total Claims
$3.0M
Total Drug Cost
149
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,105
Total Day Supply
29,249
Generic Drug Cost
$266K
Opioid Claims
25 (3.1% rate)
Antibiotic Claims
20

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
2.36
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Reza Mostofi, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
116
Ondansetron Odt
Ondansetron
59
Tagrisso
Osimertinib Mesylate
56
Prednisone
43
Eliquis
Apixaban
32
Abiraterone Acetate
31
Dexamethasone
28
Pantoprazole Sodium
23
Olanzapine
21
Prochlorperazine Maleate
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Reza Mostofi, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Reza Mostofi, M.D.'s 803 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Mostofi.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Reza Mostofi, M.D.'s specialty?
Reza Mostofi, M.D. specializes in Hematology & Oncology Physician and practices in Torrance, California. Credentials: M.D..
How much does Reza Mostofi, M.D. prescribe under Medicare Part D?
In 2023, Reza Mostofi, M.D. wrote 803 Medicare Part D claims totaling $3.0M in drug costs for 149 beneficiaries.
What is Reza Mostofi, M.D.'s Medicare quality score?
Reza Mostofi, M.D. has a CMS MIPS Final Score of 99.1/100 (Quality: 85.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Reza Mostofi, M.D. located?
Reza Mostofi, M.D. is located at 5215 TORRANCE BLVD, Torrance, CA, 90503. Phone: (310) 750-1715.
What is Reza Mostofi, M.D.'s NPI number?
Reza Mostofi, M.D.'s National Provider Identifier (NPI) is 1972786895, issued on 12/13/2007.
Does Reza Mostofi, M.D. prescribe opioids?
Yes, Reza Mostofi, M.D. had 25 opioid claims in 2023 with an opioid prescribing rate of 3.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Reza Mostofi, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Reza Mostofi, M.D.'s most frequently prescribed drugs include Anastrozole, Ondansetron Odt, Tagrisso. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Reza Mostofi, M.D. accept Medicare?
Reza Mostofi, M.D. appears in CMS Medicare data with 803 Part D claims and 149 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Reza Mostofi, M.D.'s credentials?
Reza Mostofi, M.D.'s NPI is 1972786895 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.